GLOSSARY

Fatty Acid Desaturase catalyzes fatty-acid double-bond formation.

Fatty-acid synthesis builds chains from smaller units; lipogenesis can more broadly include lipid production and storage. De novo synthesis differs from esterifying existing fatty acids. Liver and adipose contributions depend on nutritional state and require energy and reducing equivalents. Eating carbohydrate does not immediately turn all of it into fat. Stores, oxidation, total intake and time determine carbon routing, so one synthetic pathway should not be treated as the inevitable fate of every carbohydrate meal.

Esterification attaches fatty acids to suitable molecules such as glycerol structures; re-esterification reuses released fatty acids. Triglyceride assembly differs from making new fatty-acid chains. Storage is normal physiology, not automatically damage. Body-composition goals require time-integrated synthesis, breakdown and intake. Observing a post-meal storage step does not determine the result over weeks or justify avoiding all foods that transiently promote storage during ordinary recovery and feeding.

A cofactor is a nonprotein component needed by some enzymes and may be an inorganic ion or an organic molecule. A coenzyme is organic, while a prosthetic group is generally tightly associated. Apoenzyme denotes protein lacking a required cofactor, and holoenzyme the complete active form. Binding strength and role must be specified: not every substance near an enzyme is its essential cofactor.

For example, after training changes an enzyme result, first ask whether it was measured in blood, tissue or purified protein. Then assess assay conditions, nutrition and time since the last session alongside actual performance; this comparison helps distinguish a regulatory response from a nutritional deficiency or a presumed supplement need.

Flux control is usually distributed across steps, substrate supply and demand. Rate-limiting is condition-dependent rather than identifying an enzyme that always commands the whole pathway. A committed step marks more specific entry into a pathway and need not carry the greatest control. Increasing one enzyme or supplying its precursor does not guarantee greater network flux or performance without considering the wider system.

Measured activity is conversion per time under assay conditions rather than simply protein abundance. A substrate-rich assay may reveal potential capacity, while living tissue has different constraints and regulation. Units, tissue normalization and preparation methods are needed for comparison. Blood activity is not identical to intramuscular activity; laboratory changes require exercise timing, symptoms and tissue origin rather than being read as direct performance measures or a standalone diagnosis.

Training can change enzyme abundance, regulation or activity capacity depending on mode, intensity, volume and training history. An acute session response is not the same as chronic adaptation. Oxidative or glycolytic markers describe only part of performance; oxygen delivery, fuel stores and neural coordination also matter. Practical assessment therefore combines performance and recovery outcomes with adequate nutrition and the actual training program rather than relying on one enzyme marker.